Salene M W Jones1, Rebecca Ziebell2, Rod Walker2, Larissa Nekhlyudov3, Borsika A Rabin4, Stephanie Nutt5, Monica Fujii2, Jessica Chubak2. 1. Group Health Research Institute, 1730 Minor Ave, Seattle, WA, 98101, USA. wu.582@osu.edu. 2. Group Health Research Institute, 1730 Minor Ave, Seattle, WA, 98101, USA. 3. Department of Population Medicine, Harvard Medical School, 133 Brookline Avenue, 6th Floor, Boston, MA, 02215, USA. 4. Department of Family Medicine and Public Health, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. 5. Dell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.
Abstract
PURPOSE: Worry about cancer recurrence or progression is associated with negative effects of cancer, such as worse physical functioning, but associations with positive changes post-cancer, such as benefit finding, are unknown. We measured the proportion of patients reporting frequent worry about cancer recurrence or progression and examined the association between worry about cancer recurrence or progression to benefit finding and functioning in cancer. METHODS: We surveyed 594 long-term (5-10 years post-diagnosis) survivors of cancer (breast, prostate, colorectal, lung, melanoma) in this cross-sectional study. The survey asked about worry about cancer recurrence/progression, negative effects of cancer on mental and physical function, and benefit finding as a result of the cancer (positive effects). Multivariate regressions estimated associations of worry about cancer with negative and positive effects of cancer. RESULTS: Worrying about cancer often or all the time was reported by 19.6% of survivors. Worry about cancer was related to worse functioning (odds ratio (OR) range 1.40 to 1.46, all p's < .01). Worry about recurrence/progression was unrelated to benefit finding (all p's > .10). CONCLUSIONS: Worry about cancer was associated with negative, but not positive, effects of cancer. Treating worry about cancer is unlikely to reduce benefit finding after cancer. Given the high prevalence of worry about cancer and relationship to negative effects of cancer, clinical care should attempt to address this worry for long-term survivors.
PURPOSE: Worry about cancer recurrence or progression is associated with negative effects of cancer, such as worse physical functioning, but associations with positive changes post-cancer, such as benefit finding, are unknown. We measured the proportion of patients reporting frequent worry about cancer recurrence or progression and examined the association between worry about cancer recurrence or progression to benefit finding and functioning in cancer. METHODS: We surveyed 594 long-term (5-10 years post-diagnosis) survivors of cancer (breast, prostate, colorectal, lung, melanoma) in this cross-sectional study. The survey asked about worry about cancer recurrence/progression, negative effects of cancer on mental and physical function, and benefit finding as a result of the cancer (positive effects). Multivariate regressions estimated associations of worry about cancer with negative and positive effects of cancer. RESULTS: Worrying about cancer often or all the time was reported by 19.6% of survivors. Worry about cancer was related to worse functioning (odds ratio (OR) range 1.40 to 1.46, all p's < .01). Worry about recurrence/progression was unrelated to benefit finding (all p's > .10). CONCLUSIONS: Worry about cancer was associated with negative, but not positive, effects of cancer. Treating worry about cancer is unlikely to reduce benefit finding after cancer. Given the high prevalence of worry about cancer and relationship to negative effects of cancer, clinical care should attempt to address this worry for long-term survivors.
Entities:
Keywords:
Fear of recurrence; Neoplasm; Post-traumatic growth; Survivorship; Worry
Authors: K Robin Yabroff; Emily Dowling; Juan Rodriguez; Donatus U Ekwueme; Helen Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P Forsythe; Laurel Borowski; Katherine S Virgo Journal: J Cancer Surviv Date: 2012-07-19 Impact factor: 4.442
Authors: Gavin Andrews; Megan J Hobbs; Thomas D Borkovec; Katja Beesdo; Michelle G Craske; Richard G Heimberg; Ronald M Rapee; Ayelet Meron Ruscio; Melinda A Stanley Journal: Depress Anxiety Date: 2010-02 Impact factor: 6.505
Authors: Zhiyuan Zheng; K Robin Yabroff; Gery P Guy; Xuesong Han; Chunyu Li; Matthew P Banegas; Donatus U Ekwueme; Ahmedin Jemal Journal: J Natl Cancer Inst Date: 2015-12-24 Impact factor: 13.506
Authors: Maria C Katapodi; Katrina R Ellis; Franziska Schmidt; Christos Nikolaidis; Laurel L Northouse Journal: Cancer Med Date: 2018-09-05 Impact factor: 4.452